The end of Alzheimer’s?
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
44 trends tracked about this subject — the full history, oldest to newest below.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
UniQure shares tumble significantly as clinical trial data for its Huntington’s gene therapy draws conflicting reports.
Enveda secures $311 million in venture funding to advance nature-derived AI drugs into clinical trials.
Medical artificial intelligence faces an escalating proof problem as analysts demand randomized controlled trial standards before clinical integration.
A University of Utah graduate fighting stage 4 cancer is traveling to Washington D.C. to advocate for expanded clinical trial access and research funding.
The failure of heart drug trials from pharmaceutical giants Novartis and Novo Nordisk creates a significant setback for a promising field of medicine.
Bristol Myers Squibb reports successful Phase 2 results for its next-generation GPRC5D-directed CAR-T therapy targeting heavily treated myeloma patients.
A common arthritis medication, Upadacitinib, has demonstrated the ability to restore up to 100% of hair in patients suffering from severe alopecia areata.
A clinical trial has indicated that a drug developed through artificial intelligence may have the capacity to make patients biologically younger.
Rapid advancements in medical research and a surge in clinical trials have positioned an Alzheimer's cure as a tangible possibility for the first time.
Novo Nordisk faces a divergent clinical outlook as its pediatric obesity trials succeed while heart drug programs for CKD suffer setbacks.
Healthcare is navigating a critical gap as AI adoption accelerates faster than the governance and cybersecurity frameworks needed to support it.
Novo Nordisk has halted two clinical trials for Ziltivekimab, an experimental cardiovascular drug designed to reduce inflammation.
Novo Nordisk faces a diverging trajectory as it meets pediatric obesity goals but terminates two heart disease drug trials.
Novartis and Bristol Myers Squibb halt autoimmune CAR-T trials following patient deaths, impacting the sector.
Novartis and Bristol Myers Squibb halt multiple CAR-T clinical trials for autoimmune diseases following patient deaths and safety reviews.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Lipoprotein(a) moves from lab curiosity to market‑ready target as new drugs and testing surge forward
Patients facing chronic illness report significant barriers to clinical trial enrollment, ranging from physician silence to financial burdens.
Coverage reveals a third death in opaque Chinese clinical trials involving CAR-T therapy, intensifying global scrutiny.
Health authorities and global outlets report ongoing rollout discussions and upcoming trials for Ebola vaccines in the DRC.
Recent studies and reports indicate that artificial intelligence is delivering substantial cost savings and efficiency to oncology clinical trials.
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Pharmaceutical giant Novo Nordisk faces a significant setback following the failure of a late-stage cardiovascular drug trial.
Investigations are underway following a child's death in a gene-editing trial, flagged by Science-Retraction Watch reporting.
The world's first human clinical trial for a Bundibugyo ebolavirus vaccine has commenced following the first volunteer's vaccination.
Prediction market Kalshi is expanding its platform to allow users to wager on biotech clinical trial outcomes and FDA regulatory decisions.
UCSF has launched a novel clinical trial to determine if a combination of two drugs is more effective at treating Alzheimer's than a single medication.
A new oral GLP-1 receptor agonist is emerging as a potent weight-loss alternative, outperforming oral Ozempic in recent clinical trials.
Recent trial results indicate that two common medications may provide modest, short-term relief for long-COVID-related fatigue.
Recent reviews are examining the potential of creatine as an add-on therapy for depression, yielding varied results across clinical trials.
New research suggests omega-3 supplements fail to prevent Alzheimer's or improve cognitive function.
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
13 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
10 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Recent clinical trials question the efficacy of popular omega-3 supplements for preventing cognitive decline.
New evidence ties the shingles shot to a lower dementia risk, prompting calls for fast‑track vaccine trials.
13 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Clinical trials are underway for the world’s first universal coronavirus vaccine created entirely through artificial intelligence.
Pancreatic cancer treatment breakthrough sparks global medical and investment buzz
A kidney drug already used by some patients may now offer hope to millions more with non-diabetic kidney disease
A human patient has received the first experimental therapy designed to reverse cellular aging in a bid to treat age-related vision loss.